Targeted ubiquitination of Na V 1.8 reduces sensory neuronal excitability
Preprint
Abstract
Chronic pain and addiction are a significant global health challenge. Voltage-gated sodium channel Na V 1.8, a pivotal driver of pain signaling, is a clinically validated target for the development of novel, non-addictive pain therapeutics. Small molecule inhibitors against Na V 1.8 have shown promise in acute pain indications, but large clinical effect sizes have not yet been demonstrated and efficacy in chronic pain indications are lacking. An alternative strategy to target Na V 1.8 channels for analgesia is to reduce the number of channels that are present on nociceptor membranes. We generated a therapeutic heterobifunctional protein, named UbiquiNa V , that contains a Na V 1.8-selective binding module and the catalytic subunit of the NEDD4 E3 Ubiquitin ligase. We show that UbiquiNav significantly reduces channel expression in the plasma membrane and reduces Na V 1.8 currents in rodent sensory neurons. We demonstrate that UbiquiNa V is selective for Na V 1.8 over other Na V isoforms and other components of the sensory neuronal electrogenisome. We then show that UbiquiNa V normalizes the distribution of Na V 1.8 protein to distal axons, and that UbiquiNa V normalizes the neuronal hyperexcitability in in vitro models of inflammatory and chemotherapy-induced neuropathic pain. Our results serve as a blueprint for the design of therapeutics that leverage the selective ubiquitination of Na V 1.8 channels for analgesia.Keywords
This publication has 78 references indexed in Scilit:
- Compartment-specific regulation of NaV1.7 in sensory neurons after acute exposure to TNF-αCell Reports, 2024
- The fates of internalized NaV1.7 channels in sensory neurons: Retrograde cotransport with other ion channels, axon-specific recycling, and degradationJournal of Biological Chemistry, 2022
- Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast CancerJAMA Network Open, 2022
- Biologics-based degraders — an expanding toolkit for targeted-protein degradationCurrent Opinion in Biotechnology, 2022
- The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful NeuropathyNeuroMolecular Medicine, 2015
- TNF-α enhances the currents of voltage gated sodium channels in uninjured dorsal root ganglion neurons following motor nerve injuryExperimental Neurology, 2011
- The Prevalence of Chronic Pain in United States Adults: Results of an Internet-Based SurveyThe Journal of Pain, 2010
- Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatmentEuropean journal of pain, 2006
- Effects of interleukin-1 beta, interleukin-6, and tumor necrosis factor on sensitivity of dorsal root ganglion and peripheral receptive fields in ratsEuropean Spine Journal, 2006
- CAP-1A is a novel linker that binds clathrin and the voltage-gated sodium channel Nav1.8Molecular and Cellular Neuroscience, 2005